New York, NY, March 1, 2016 – Despite many advances in the treatment of type 1 diabetes (T1D), most people with T1D struggle to achieve recommended glucose control guidelines, and are at risk of low blood sugar emergencies and long-term complications. While technologies have made a significant impact on monitoring, management, and treatment of the disease, data from T1D Exchange reveal that only 40 percent of people living with T1D use insulin pumps and less than 15 percent use continuous glucose monitors.
↧